649 related articles for article (PubMed ID: 22867712)
1. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
Dickerson TJ; Suzuki E; Stanecki C; Shin HS; Qui H; Adamopoulos IE
J Autoimmun; 2012 Dec; 39(4):369-76. PubMed ID: 22867712
[TBL] [Abstract][Full Text] [Related]
2. Synovial fluid macrophages are capable of osteoclast formation and resorption.
Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
[TBL] [Abstract][Full Text] [Related]
3. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY
Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of osteoclast formation by inflammatory synovial fluid.
Adamopoulos IE; Danks L; Itonaga I; Locklin RM; Sabokbar A; Ferguson DJ; Athanasou NA
Virchows Arch; 2006 Jul; 449(1):69-77. PubMed ID: 16642388
[TBL] [Abstract][Full Text] [Related]
5. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis.
Kim KW; Kim HR; Kim BM; Cho ML; Lee SH
Am J Pathol; 2015 Nov; 185(11):3011-24. PubMed ID: 26362732
[TBL] [Abstract][Full Text] [Related]
6. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways.
Li X; Kim KW; Cho ML; Ju JH; Kang CM; Oh HJ; Min JK; Lee SH; Park SH; Kim HY
Immunol Lett; 2010 Jan; 127(2):100-7. PubMed ID: 19900478
[TBL] [Abstract][Full Text] [Related]
7. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.
Kotake S; Udagawa N; Hakoda M; Mogi M; Yano K; Tsuda E; Takahashi K; Furuya T; Ishiyama S; Kim KJ; Saito S; Nishikawa T; Takahashi N; Togari A; Tomatsu T; Suda T; Kamatani N
Arthritis Rheum; 2001 May; 44(5):1003-12. PubMed ID: 11352231
[TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
Kim HR; Kim KW; Jung HG; Yoon KS; Oh HJ; Cho ML; Lee SH
Arthritis Res Ther; 2011 Mar; 13(2):R43. PubMed ID: 21401926
[TBL] [Abstract][Full Text] [Related]
9. Synovial macrophage-osteoclast differentiation in inflammatory arthritis.
Danks L; Sabokbar A; Gundle R; Athanasou NA
Ann Rheum Dis; 2002 Oct; 61(10):916-21. PubMed ID: 12228163
[TBL] [Abstract][Full Text] [Related]
10. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S
Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864
[TBL] [Abstract][Full Text] [Related]
11. Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
Adamopoulos IE; Wordsworth PB; Edwards JR; Ferguson DJ; Athanasou NA
Hum Pathol; 2006 Sep; 37(9):1176-85. PubMed ID: 16938523
[TBL] [Abstract][Full Text] [Related]
12. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
Dai SM; Nishioka K; Yudoh K
Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
[TBL] [Abstract][Full Text] [Related]
13. The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis.
Kim HR; Kim KW; Kim BM; Cho ML; Lee SH
PLoS One; 2015; 10(4):e0124909. PubMed ID: 25894998
[TBL] [Abstract][Full Text] [Related]
14. Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts.
Nakano K; Okada Y; Saito K; Tanaka Y
Arthritis Rheum; 2004 Aug; 50(8):2450-8. PubMed ID: 15334457
[TBL] [Abstract][Full Text] [Related]
15. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
[TBL] [Abstract][Full Text] [Related]
16. Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin.
Hase H; Kanno Y; Kojima H; Sakurai D; Kobata T
Arthritis Rheum; 2008 Nov; 58(11):3356-65. PubMed ID: 18975335
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal activation of CD4+ T cells and synovial fibroblasts by stromal cell-derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis.
Kim HR; Kim KW; Kim BM; Jung HG; Cho ML; Lee SH
Arthritis Rheumatol; 2014 Mar; 66(3):538-48. PubMed ID: 24574213
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.
Kim KW; Kim HR; Park JY; Park JS; Oh HJ; Woo YJ; Park MK; Cho ML; Lee SH
Arthritis Rheum; 2012 Apr; 64(4):1015-23. PubMed ID: 22034096
[TBL] [Abstract][Full Text] [Related]
19. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
Romas E; Gillespie MT; Martin TJ
Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
[TBL] [Abstract][Full Text] [Related]
20. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.
Hirayama T; Danks L; Sabokbar A; Athanasou NA
Rheumatology (Oxford); 2002 Nov; 41(11):1232-9. PubMed ID: 12421995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]